Abstract: A surface-reacted calcium carbonate is described. In embodiments, the surface-reacted calcium carbonate is obtained by a process comprising treating a calcium carbonate-comprising material with at least one H3O+ ion donor, carbon dioxide, and at least one water-soluble metal cation source in an aqueous medium to form an aqueous suspension of surface-reacted calcium carbonate.

Abstract: The invention relates to a process for reducing the minimum inhibitory concentration (MIC) of a biocide against at least one strain of bacteria and/or at least one strain of yeast and/or at least one strain of mould in an aqueous preparation. The invention further relates to the use of a water soluble source of lithium ions for reducing the minimum inhibitory concentration (MIC) of a biocide against at least one strain of bacteria and/or at least one strain of yeast and/or at least one strain of mould in an aqueous preparation.

Abstract: Use of urea as an antimicrobial additive in an aqueous suspension, comprising from 5 to 85 wt.-%, based on the total weight of the suspension, of at least one calcium carbonate-comprising material and having a pH of between 7.0 and 14, a process for preserving an aqueous suspension against microbial growth, an aqueous preparation obtainable by the inventive process as well as the use of the aqueous preparation in agriculture.

Abstract: A method of providing micronutrient delivery and/or plant protection is described, the method comprising administering a surface-reacted calcium carbonate as a metal cation releaser to deliver the micronutrient and/or provide plant protection. The surface-reacted calcium carbonate is obtained by a process comprising treating a calcium carbonate-comprising material with at least one H3O+ ion donor, carbon dioxide, and at least one water-soluble metal cation source in an aqueous medium to form an aqueous suspension of surface-reacted calcium carbonate.

Abstract: A method of preserving, controlling an odor, and/or enhancing and/or mediating antimicrobial activity of a substrate is described, the method comprising administering a surface-reacted calcium carbonate. The surface-reacted calcium carbonate is obtained by a process comprising treating a calcium carbonate-comprising material with at least one H3O+ ion donor, carbon dioxide, and at least one water-soluble metal cation source in an aqueous medium to form an aqueous suspension of surface-reacted calcium carbonate.

Abstract: A surface-reacted calcium carbonate is described. In embodiments, the surface-reacted calcium carbonate is obtained by a process comprising treating a calcium carbonate-comprising material with at least one H3O+ ion donor, carbon dioxide, and at least one water-soluble metal cation source in an aqueous medium to form an aqueous suspension of surface-reacted calcium carbonate.

Abstract: A process of producing a surface-reacted calcium carbonate is described. In embodiments, a calcium carbonate-comprising material is treated with at least one H3O+ ion donor, carbon dioxide, and at least one water-soluble metal cation source in an aqueous medium to form an aqueous suspension of surface-reacted calcium carbonate. A surface-reacted calcium carbonate obtained by said process and its use are also described.

Abstract: The invention relates to a process for reducing the minimum inhibitory concentration (MIC) of a biocide against at least one strain of bacteria and/or at least one strain of yeast and/or at least one strain of mould in an aqueous preparation. The invention further relates to the use of a water soluble source of lithium ions for reducing the minimum inhibitory concentration (MIC) of a biocide against at least one strain of bacteria and/or at least one strain of yeast and/or at least one strain of mould in an aqueous preparation.

Abstract: A process is described for the surface-treatment of a surface-reacted calcium carbonate. Also described, is a surface-treated surface-reacted calcium carbonate obtainable by the process, as well a composition including the surface-treated surface-reacted calcium carbonate . Methods of using at least one surface-reacted calcium carbonate for immobilizing at least one water soluble metal salt, water soluble metal hydroxide, water soluble metal oxide or mixtures thereof on the surface of the at least one surface-reacted calcium carbonate are also described. In addition, methods of using a surface-treated surface-reacted calcium carbonate as a preservative, for the control of odor and/or for enhancing and/or mediating antimicrobial activity of a substrate and an article including the surface-treated surface-reacted calcium carbonate are described.

Abstract: The invention relates to a process for reducing the minimum inhibitory concentration (MIC) of a biocide against at least one strain of bacteria and/or at least one strain of yeast and/or at least one strain of mould in an aqueous preparation. The invention further relates to the use of a water soluble source of lithium ions for reducing the minimum inhibitory concentration (MIC) of a biocide against at least one strain of bacteria and/or at least one strain of yeast and/or at least one strain of mould in an aqueous preparation.

Abstract: The present invention relates to a modified mineral-based filler comprising at least one alkaline earth metal carbonate-comprising material, and at least one water insoluble copper salt comprising the copper mineral malachite in an amount of at least 10 wt.-%, which covers at least partially the surface of the at least one alkaline earth metal carbonate-comprising material, and a method of producing the same.

Abstract: The present invention provides antigenic polypeptides expressed during an infection by a pathogenic organism, such as Acinetobacter and compositions comprising these polypeptides. The invention further provides compositions for use in treating, preventing or detecting a bacterial infection, in particular vaccine compositions using the antigenic polypeptides. The invention further provides antibodies directed to said antigenic polypeptides.

Abstract: The present invention relates to a process for preparing an antiseptic product, an antiseptic product obtainable by the process, an antiseptic inorganic powder composition, an antiseptic polymer product as well as the use of one or more source of lithium ions in combination with one or more source of sodium ions for the preparation of an antiseptic product being effective against microbial contamination.

Abstract: The present invention provides antigenic polypeptides expressed during an infection by a pathogenic organism, such as Acinetobacter and compositions comprising these polypeptides. The invention further provides compositions for use in treating, preventing or detecting a bacterial infection, in particular vaccine compositions using the antigenic polypeptides. The invention further provides antibodies directed to said antigenic polypeptides.

Abstract: The present invention provides antigenic polypeptides expressed during an infection by a pathogenic organism, such as Acinetobacter and compositions comprising these polypeptides. The invention further provides compositions for use in treating, preventing or detecting a bacterial infection, in particular vaccine compositions using the antigenic polypeptides. The invention further provides antibodies directed to said antigenic polypeptides.

Abstract: A process is described for stabilizing an aqueous preparation against microbial growth. Also described, is the aqueous preparation stabilized against microbial growth as well as the use of a source of at least one metal oxide and/or its hydrated form for reducing the amount of an antimicrobial agent against at least one strain of bacteria and/or at least one strain of yeast and/or at least one strain of mold in an aqueous preparation. The use of a composition including at least one antimicrobial agent and a source of at least one metal oxide and/or its hydrated form as an antimicrobial composition in an aqueous preparation, is also described.

Abstract: The present invention provides antigenic polypeptides expressed during an infection by a pathogenic organism, such as Acinetobacter and compositions comprising these polypeptides. The invention further provides compositions for use in treating, preventing or detecting a bacterial infection, in particular vaccine compositions using the antigenic polypeptides. The invention further provides antibodies directed to said antigenic polypeptides.

Abstract: The present invention provides antigenic polypeptides expressed during an infection by a pathogenic organism, such as Acinetobacter and compositions comprising these polypeptides. The invention further provides compositions for use in treating, preventing or detecting a bacterial infection, in particular vaccine compositions using the antigenic polypeptides. The invention further provides antibodies directed to said antigenic polypeptides.

Abstract: The present invention provides antigenic polypeptides expressed during an infection by a pathogenic organism, such as Acinetobacter and compositions comprising these polypeptides. The invention further provides compositions for use in treating, preventing or detecting a bacterial infection, in particular vaccine compositions using the antigenic polypeptides. The invention further provides antibodies directed to said antigenic polypeptides.

Abstract: The present invention relates to nucleic acids and methods for detecting pathogens and beneficial microorganisms.